SCG Cell Therapy website screenshot

SCG Cell Therapy

SCG Cell Therapy Pte. Ltd. is a clinical-stage biotechnology company headquartered in Singapore, with operations across Singapore, China and Germany, developing novel immunotherapies for infectious diseases and the cancers they cause. The company targets the most common cancer-causing infections — Helicobacter pylori, human papillomavirus (HPV), hepatitis B virus (HBV) and Epstein-Barr virus (EBV) — and is advancing a pipeline of TCR-engineered T cell therapies, antibodies and therapeutic vaccines built on its proprietary GianTCR platform. Lead programs include SCG101, a first-in-class autologous HBV-specific TCR-T therapy targeting hepatitis B surface antigen in HBV-related hepatocellular carcinoma, and SCG142, a next-generation HPV E7-specific TCR-T therapy for HPV-associated solid tumors that received FDA IND clearance. SCG covers the full value chain from drug discovery and manufacturing through clinical development and commercialization. It is a therapeutics developer, not a software vendor, and publishes no public API, developer portal or machine-readable contract.

SCG Cell Therapy is profiled on the APIs.io network. Tagged areas include Biotechnology, Cell Therapy, Immunotherapy, Oncology, and Infectious Diseases.

2.9/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-09-02 · rubric v0.18.0
0 APIs
BiotechnologyCell TherapyImmunotherapyOncologyInfectious DiseasesClinical TrialsLife SciencesHealthcarePharmaceuticalsSingapore

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-09-02 · rubric v0.18.0
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/scg-cell-therapy: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Scg Cell Therapy Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

Access & Security 1

Authentication, authorization, and security posture

Company 2

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: scg-cell-therapy
name: SCG Cell Therapy
description: SCG Cell Therapy Pte. Ltd. is a clinical-stage biotechnology company headquartered in Singapore, with operations
  across Singapore, China and Germany, developing novel immunotherapies for infectious diseases and the cancers they cause.
  The company targets the most common cancer-causing infections — Helicobacter pylori, human papillomavirus (HPV), hepatitis
  B virus (HBV) and Epstein-Barr virus (EBV) — and is advancing a pipeline of TCR-engineered T cell therapies, antibodies
  and therapeutic vaccines built on its proprietary GianTCR platform. Lead programs include SCG101, a first-in-class autologous
  HBV-specific TCR-T therapy targeting hepatitis B surface antigen in HBV-related hepatocellular carcinoma, and SCG142, a
  next-generation HPV E7-specific TCR-T therapy for HPV-associated solid tumors that received FDA IND clearance. SCG covers
  the full value chain from drug discovery and manufacturing through clinical development and commercialization. It is a therapeutics
  developer, not a software vendor, and publishes no public API, developer portal or machine-readable contract.
url: https://raw.githubusercontent.com/api-evangelist/scg-cell-therapy/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
deliveryModel:
  model: unknown
  open_source: false
  commercial: false
  callable_host: false
  label: Delivery model not determined — needs a product licence on record
  confidence: low
  source:
  - none
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source:
  - security
  generated: '2026-09-02'
  method: derived
specificationVersion: '0.20'
created: '2026-08-26'
modified: '2026-08-26'
tags:
- Biotechnology
- Cell Therapy
- Immunotherapy
- Oncology
- Infectious Diseases
- Clinical Trials
- Life Sciences
- Healthcare
- Pharmaceuticals
- Singapore
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/scg-cell-therapy-domain-security.yml
- type: Website
  url: https://www.scgcell.com/
- type: LinkedIn
  url: https://sg.linkedin.com/company/scgcell
- type: LLMsTxt
  url: llms/scg-cell-therapy-llms.txt
x-enrichment:
  date: '2026-08-26'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: SCG Cell Therapy is a clinical-stage TCR-T cell therapy developer whose only web property is an Alibaba Cloud site-builder
    marketing site; there is no developer portal, no api./developer./docs. subdomain resolves in DNS, and no GitHub organization
    exists under any spelling of the company name.
  evidence:
  - url: https://www.scgcell.com/
    status: 200
  - url: https://www.scgcell.com/openapi.json
    status: 404
  - url: https://www.scgcell.com/llms.txt
    status: 404
  - url: https://api.github.com/orgs/scgcell
    status: 404
  - url: https://www.scgcell.com/.well-known/security.txt
    status: 429
  checked: '2026-08-26'

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this
  • find_providersBrowse and filter every provider in the catalog.
  • get_provider_artifactsEvery artifact this provider publishes, grouped by type.
  • get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
  • get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
  • get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
  • get_provider_ratingPRO — composite, band, trend and facet scores.
  • apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
  • resolveTurn a domain, URL or GitHub org into the provider it belongs to.
  • find_cohortsEvery scored population of providers in the catalog.
All 92 tools →

Call it yourself

curl for this page
This provider
curl "https://apis.io/api/v1/providers/scg-cell-therapy"
All providers
curl "https://apis.io/api/v1/providers?limit=25"
Every operation they expose
curl "https://apis.io/api/v1/providers/scg-cell-therapy/operations?limit=25"
How their score was established
curl "https://apis.io/api/v1/providers/scg-cell-therapy/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no email required.

A second provider on the same verified email joins the account you already have.